Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3904591rdf:typepubmed:Citationlld:pubmed
pubmed-article:3904591lifeskim:mentionsumls-concept:C0005695lld:lifeskim
pubmed-article:3904591lifeskim:mentionsumls-concept:C1141639lld:lifeskim
pubmed-article:3904591lifeskim:mentionsumls-concept:C1441616lld:lifeskim
pubmed-article:3904591pubmed:issue5lld:pubmed
pubmed-article:3904591pubmed:dateCreated1985-12-16lld:pubmed
pubmed-article:3904591pubmed:abstractTextAll transitional cell carcinomas of the bladder diagnosed in male patients within a five year period were studied for human chorionic gonadotropin (hCG) production. Biotin-avidin immunoperoxidase analysis for hCG was performed on all paraffin blocks containing carcinoma-in-situ, grade I, grade II, and grade III transitional cell carcinoma. Of a total of 29 patients, one case of carcinoma-in-situ (1/5), and five cases of grade III transitional cell carcinoma (5/15) were found to have hCG-positive tumor cells. The findings indicate that transitional cell carcinoma should be added to the list of malignant tumors capable of producing hCG.lld:pubmed
pubmed-article:3904591pubmed:languageenglld:pubmed
pubmed-article:3904591pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3904591pubmed:citationSubsetIMlld:pubmed
pubmed-article:3904591pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3904591pubmed:statusMEDLINElld:pubmed
pubmed-article:3904591pubmed:issn0091-7370lld:pubmed
pubmed-article:3904591pubmed:authorpubmed-author:GondosBBlld:pubmed
pubmed-article:3904591pubmed:authorpubmed-author:LoukCClld:pubmed
pubmed-article:3904591pubmed:authorpubmed-author:YamaseH THTlld:pubmed
pubmed-article:3904591pubmed:authorpubmed-author:WurzelR SRSlld:pubmed
pubmed-article:3904591pubmed:issnTypePrintlld:pubmed
pubmed-article:3904591pubmed:volume15lld:pubmed
pubmed-article:3904591pubmed:ownerNLMlld:pubmed
pubmed-article:3904591pubmed:authorsCompleteYlld:pubmed
pubmed-article:3904591pubmed:pagination414-7lld:pubmed
pubmed-article:3904591pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3904591pubmed:meshHeadingpubmed-meshheading:3904591-...lld:pubmed
pubmed-article:3904591pubmed:meshHeadingpubmed-meshheading:3904591-...lld:pubmed
pubmed-article:3904591pubmed:meshHeadingpubmed-meshheading:3904591-...lld:pubmed
pubmed-article:3904591pubmed:meshHeadingpubmed-meshheading:3904591-...lld:pubmed
pubmed-article:3904591pubmed:meshHeadingpubmed-meshheading:3904591-...lld:pubmed
pubmed-article:3904591pubmed:meshHeadingpubmed-meshheading:3904591-...lld:pubmed
pubmed-article:3904591pubmed:meshHeadingpubmed-meshheading:3904591-...lld:pubmed
pubmed-article:3904591pubmed:meshHeadingpubmed-meshheading:3904591-...lld:pubmed
pubmed-article:3904591pubmed:meshHeadingpubmed-meshheading:3904591-...lld:pubmed
pubmed-article:3904591pubmed:meshHeadingpubmed-meshheading:3904591-...lld:pubmed
pubmed-article:3904591pubmed:meshHeadingpubmed-meshheading:3904591-...lld:pubmed
pubmed-article:3904591pubmed:articleTitleImmunohistochemical demonstration of human chorionic gonadotropin in tumors of the urinary bladder.lld:pubmed
pubmed-article:3904591pubmed:publicationTypeJournal Articlelld:pubmed